Loading organizations...
Loading organizations...
Vee is a technology company.
Vee develops an AI-powered platform tailored for nonprofit organizations, providing intelligent automation tools that streamline critical operational functions. The core offering includes dedicated AI agents designed to assist with grant discovery, grant writing, and comprehensive fundraising management, thereby enabling nonprofits to enhance their impact and operational efficiency without proportional increases in headcount. This technology helps automate complex administrative tasks, allowing organizations to focus more on their mission.
The company was founded in 2020 by May Piamenta and Avi Amor. Their initial venture was a marketplace connecting volunteers with nonprofits; however, they strategically pivoted the business model. This shift was driven by the insight that leveraging artificial intelligence could more effectively address the core challenges nonprofits face, particularly in securing funding and managing donor relations, leading to the creation of their current AI-driven solution.
Vee primarily serves the nonprofit sector, empowering these organizations with sophisticated yet accessible AI tools. The company’s long-term vision is to become an essential partner for nonprofits, making fundraising, communication, and overall growth more manageable and effective through intelligent automation. They aim to democratize access to advanced technological capabilities, fostering a future where nonprofits can scale their societal contributions through efficient digital tools.
Vee has raised $19.0M across 2 funding rounds.
Vee has raised $19.0M in total across 2 funding rounds.
Vee Healthtek (formerly Vee Technologies) is a technology-enabled professional services firm specializing in healthcare solutions, including claims processing, consulting, engineering, IT services, and finance support for health systems, hospitals, pharmaceutical companies, and physician groups.[1][2] Headquartered in New York City and Bangalore, it serves Fortune 500 companies and mid-sized organizations globally, focusing on cost reduction, operational streamlining, and growth acceleration through personalized, innovative technology solutions.[1][2][4] Its mission is "To Globalize Success to Make Lives Better" by creating value for clients, employees, and stakeholders, with a vision to lead the global services industry via technology, innovation, and education.[2][3]
The company emphasizes HIPAA compliance and ISO 9001:2015 certification, delivering results across sectors while prioritizing accuracy, competency, and teamwork.[2] In 2024, it rebranded to Vee Healthtek to highlight its expanding healthcare portfolio, building on decades of growth from its origins in business management and IT.[1]
Vee Healthtek traces its roots to the Sona Valliappa Group, founded over 100 years ago in pre-independence India by an entrepreneur who established 19 institutions, some of which still provide talent to the company today.[1] In 1984, the group entered business management and created India's first IT development center.[1] Vee Technologies Pvt. Ltd. was formally launched in 2000 by the Sona Group as a claims processing company for major healthcare organizations, under the leadership of CEO & MD Chocko Valliappa, a fourth-generation entrepreneur from the group's legacy.[1][2]
After a decade of rapid expansion—including new units in consulting, engineering, IT, and finance—the company opened its New York headquarters around 2010 and partnered with hundreds of Fortune 500 firms, earning awards for cross-sector solutions.[1] Pivotal moments include sustained growth serving global clients and the 2024 rebranding to Vee Healthtek, sharpening its focus on healthcare amid rising demand for tech-driven services.[1]
Vee Healthtek rides the wave of digital transformation in healthcare, where rising costs, regulatory pressures, and demand for efficiency drive outsourcing of claims, IT, and analytics to tech-savvy providers.[1][3] Its timing aligns with post-pandemic shifts toward streamlined payer-provider operations and AI-enhanced services, positioning it to capitalize on global market forces like healthcare digitization and cost optimization.[1][2] By partnering with Fortune 500 healthcare giants, it influences the ecosystem through scalable solutions that reduce overhead while boosting outcomes, contributing to broader trends in strategic, interdependent business models.[3][4]
Vee Healthtek is poised for continued expansion in healthcare tech services, potentially deepening AI integrations for predictive analytics and automation amid growing global demand.[1][3] Trends like value-based care, data interoperability, and telemedicine will shape its trajectory, amplifying its role as a bridge between legacy systems and innovative outcomes.[2] Its influence may evolve by scaling educational initiatives and cross-sector expertise, solidifying leadership in a fragmented professional services market—echoing its foundational promise to globalize success through technology and human capital.[1][2]
Vee has raised $19.0M in total across 2 funding rounds.
Vee's investors include Horizon Capital, Innovation Endeavors, Matias Ventures, NFX, State of Mind Ventures, TLV Partners, Gil Hirsch, Itai Elizur, Joey Low, 91 Ventures, A Capital, American Express Ventures.
Vee has raised $19.0M across 2 funding rounds. Most recently, it raised $7.0M Seed in July 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2024 | $7.0M Seed | Horizon Capital, Innovation Endeavors, Matias Ventures, NFX, State of Mind Ventures, TLV Partners, Gil Hirsch, Itai Elizur, Joey Low | |
| Feb 1, 2022 | $12.0M Seed | State of Mind Ventures | 91 Ventures, A Capital, American Express Ventures, Arbor Ventures, Blackhorn Ventures, Bow Capital, Company Capital, Cyberstarts VC, Differential Ventures, Eight Roads Ventures, Felicis Ventures, Graph Ventures, Horizon Capital, Innovation Endeavors, Insight Partners, Liquid 2 Ventures, Matias Ventures, NFX, SV Angel, TLV Partners, Unpopular Ventures, Viola Ventures, Vital Capital, Zetta Venture Partners, Abrahami Avishai, Frederic Kerrest, Gil Hirsch, Immad Akhund, Itai Elizur, Joey Low, Michael Ma, Ronny Conway, Ryan Carlson |